Although the COVID-19 pandemic has profoundly disrupted many research studies, it has also accelerated development and use of remote assessment tools for cognition. The UCSF Brain Health Registry (BHR), an online research registry of over 100,000 adult volunteers, has been an innovator in this area and has continued to move forward.
Through the Electronic Validation (eVAL) Study, my team and I are validating new, online assessments that evaluate a person’s cognition, functioning, and decline. Leveraging self- administered remote assessment to identify, diagnose, and longitudinally monitor individuals at risk for Alzheimer’s can positively impact dementia research, and accelerate the search for treatments.
Our team has also made strides in remote biospecimen collection and analysis. Blood and genetic material contain valuable biomarkers that can help evaluate dementia risk…
_3.jpg&description=Updates+From+Michael+Weiner%2C+MD+Principal+Investigator+of+the+UCSF+Brain+Health+Registry){kind=link}